Search research articles
Contact Us
Filters
Showing results (61-70 of 156) with videos related to
Page
of 16
Sort By:
European Journal of Haematology
|
March 26, 2014
Experts' considerations on HLA-haploidentical stem cell transplantation
Francesca Patriarca, Leo Luznik, Marta Medeot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group
Francesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Blood
|
October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
Attilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.
Haematologica
|
April 12, 2008
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, et al.
European Journal of Haematology
|
March 3, 2007
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma
Benedetto Bruno, Roberto Sorasio, Francesca Patriarca, et al.
The New England Journal of Medicine
|
March 16, 2007
A comparison of allografting with autografting for newly diagnosed myeloma
Benedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Cancer
|
June 28, 2021
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network
Francesca Gay, Andreas Günther, Massimo Offidani, et al.
Hemasphere
|
October 7, 2022
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, et al.
Leukemia & Lymphoma
|
June 1, 2010
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
Monika Engelhardt, Martina Kleber, Josefina Udi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2007
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
Michele Cavo, Patrizia Tosi, Elena Zamagni, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 156) with videos related to
Sort By:
Page
of 16
European Journal of Haematology
|
March 26, 2014
Experts' considerations on HLA-haploidentical stem cell transplantation
Francesca Patriarca, Leo Luznik, Marta Medeot, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group
Francesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Blood
|
October 25, 2013
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
Attilio Olivieri, Michele Cimminiello, Paolo Corradini, et al.
Haematologica
|
April 12, 2008
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, et al.
European Journal of Haematology
|
March 3, 2007
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma
Benedetto Bruno, Roberto Sorasio, Francesca Patriarca, et al.
The New England Journal of Medicine
|
March 16, 2007
A comparison of allografting with autografting for newly diagnosed myeloma
Benedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Cancer
|
June 28, 2021
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network
Francesca Gay, Andreas Günther, Massimo Offidani, et al.
Hemasphere
|
October 7, 2022
Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, et al.
Leukemia & Lymphoma
|
June 1, 2010
Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches
Monika Engelhardt, Martina Kleber, Josefina Udi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2007
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
Michele Cavo, Patrizia Tosi, Elena Zamagni, et al.
Page
of 16